Balli RX SRL
Balli RX reported total assets of 393,045 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Oct 2026).
The score of Balli RX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +21600 % Total assets +16168 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Balli RX's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Oct 2026
- Year ended 31 Dec 2024filed on 26 Sep 2025
- Year ended 31 Dec 2023filed on 16 Sep 2024
Balli RX's financial analysis
- Solvency61.6%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Balli RX
Balli RX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0795.362.089
- VAT number
- BE0795362089
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 23 Dec 2022
- Registered office
- 5024 Namur
- Latest accounts
- 2025 · filed on 02 Oct 2026
- Activity
- Medical specialists activities (NACE 86220)
Balli RX (SRL) has been based in Namur since 2022, active in: medical specialists activities. For 2025, it reports a net profit of 109,395 € and equity of 242,168 €; its revenue is not published. Its solvency stands at 61.6%, below the median of its sector (65.0%).
Companies similar to Balli RX
Companies in the same business, of comparable size and area, outside its group.
- Monimmo Manufacture of basic pharmaceutical products Zandhoven · balance sheet 392,963 €
- Health Care Strategies Business and other management consultancy activities Auderghem · balance sheet 393,386 €
- Ndjoumi Patrice Molenbeek-Saint-Jean · balance sheet 392,718 €
- SAMVA Cabinet Médical Dison · balance sheet 392,707 €
- Immobiliere DU Bois D'Hairmont Morlanwelz · balance sheet 392,566 €
Frequently asked questions about Balli RX
What is the revenue of Balli RX?
Balli RX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Balli RX?
In Belgium, the VAT number is the company number prefixed with BE: BE0795362089 for Balli RX, if the company is VAT-registered. Its company number (CBE) is 0795.362.089.
Where is the registered office of Balli RX?
According to the CBE register, the registered office of Balli RX is in 5024 Namur.
What is the equity of Balli RX?
At the close of the 2025 financial year, the equity of Balli RX amounts to 242,168 €, a solvency of 61.6% of total assets.
Who manages Balli RX?
The register lists 1 active mandates at Balli RX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Balli RX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →